Provexis (PXS)

 

Latest News

Holding(s) in Company

RNS Number: 6083M Provexis PLC 04 August 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Provexis plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposa...

Results of placing

RNS Number: 5434M Provexis PLC 31 July 2017 31 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS I...

Funding Update

RNS Number: 4846M Provexis PLC 28 July 2017 28 July 2017 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS...

Funding Update

RNS Number: 8750J Provexis PLC 03 July 2017 3 July 2017 Provexis plc Funding update Provexis plc ('Provexis' or the 'Company'), the business that develops, licenses and sells the proprietary, scientifically-proven Fruitflow heart-health functional food ingredient, is pleased to announce a funding update. First Subscription - completed in May 2017 The Company confirm...

All News

DateHeadlineSource
04-08-17Holding(s) in CompanyRNS
31-07-17Results of placingRNS
28-07-17Funding UpdateRNS
03-07-17Funding UpdateRNS
09-06-17Price Monitoring ExtensionRNS
05-06-17Second Price Monitoring ExtnRNS
05-06-17Price Monitoring ExtensionRNS
19-05-17Second Price Monitoring ExtnRNS
19-05-17Price Monitoring ExtensionRNS
17-05-17Holding(s) in CompanyRNS
10-05-17Provexis expects to report on strong year of progressStockMarketWire
02-05-17Funding UpdateRNS
11-04-17Second Price Monitoring ExtnRNS
11-04-17Price Monitoring ExtensionRNS
06-04-17FTSE bogged down by ex-divs after Wall St fallsStockMarketWire
06-04-17Provexis in MoU for R&D with By-Health Co LtdStockMarketWire
06-04-17By-Health MOU and product launch for FruitflowRNS
08-02-17Second Price Monitoring ExtnRNS
08-02-17Price Monitoring ExtensionRNS
30-12-16Provexis narrows H1 pretax lossStockMarketWire
30-12-16Half-year ReportRNS
21-12-16Second Price Monitoring ExtnRNS
21-12-16Price Monitoring ExtensionRNS
20-12-16FTSE supported by banks after MBNA acquisition StockMarketWire
20-12-16Weak commodity prices drag miners lowerStockMarketWire
20-12-16Provexis reports positive results from Fruitflow pilot study StockMarketWire
20-12-16Fruitflow and Blood Pressure - second stage updateRNS
01-12-16Has Provexis stopped the rot?Interactive Investor
30-11-16Trends and Targets for 1/12/2016Trends and Targets
23-11-16Study publication - comparison with aspirinRNS
18-11-16Mortgage data and commodity price weakness keeps FTSE in the redStockMarketWire
18-11-16New Collaboration for FruitflowRNS
30-09-16Result of AGMRNS
15-09-16Director/PDMR ShareholdingRNS
07-09-16Provexis reduces FY pretax lossStockMarketWire
07-09-16Preliminary ResultsRNS
02-09-16Holding(s) in CompanyRNS
02-08-16Provexis raises £224,000 at 0.24p/shareStockMarketWire
02-08-16Results of PlacingRNS
12-07-16Study PublicationRNS

RSS feeds

  • Editorial news feed for LSE:PXS Editorial
  • Regulatory news feed for LSE:PXS Regulatory